• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Sernova Corp (OP: SEOVF )

    0.2341 +0.0210 (+9.85%)
    Streaming Delayed Price Updated: 9:30 AM EDT, Jun 13, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 3,500
    Open 0.2131
    Bid (Size) N/A (0)
    Ask (Size) N/A (0)
    Prev. Close 0.2131
    Today's Range 0.2341 - 0.2341
    52wk Range 0.1961 - 0.8329
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Sernova Provides Positive Clinical and Platform Portfolio Update
    With recent positive findings in post-surgical hypothyroidism large animal study, Sernova anticipates filing an Investigational New Drug (IND) application in 2024 
    Via TheNewswire.com
    Sernova Announces Peer Reviewed Publication Demonstrating Safety and Efficacy of a Novel Cell Pouch Cell Therapy Approach for Treatment of Severe Hemophilia A
    LONDON, ONTARIO – TheNewswire - January 20, 2022 – Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE/XETRA:PSH), a clinical-stage regenerative medicine and cell therapy therapeutics company developing a... 
    Via TheNewswire.com

    Performance

    YTD
    -57.23%
    -57.23%
    1 Month
    -8.98%
    -8.98%
    3 Month
    -45.46%
    -45.46%
    6 Month
    -54.89%
    -54.89%
    1 Year
    -63.98%
    -63.98%

    More News

    Read More
    Sernova to Present Corporate Update at Canaccord Genuity's 41st Annual Growth Conference
    Via TheNewswire.com
    Exposures COVID-19
    Sernova Announces 2021 Annual Meeting Results: Shareholders Approve Resolutions with Overwhelming Majority
    Via TheNewswire.com
    Exposures COVID-19
    Industry Veteran Frank Shannon Joins Sernova as VP Clinical Development and Regulatory Affairs
    Via TheNewswire.com
    Exposures COVID-19
    Sernova's Principal Investigator Presents Interim Data and Positive Patient Outcomes of Phase I/II T1D Study at the American Diabetes Association 81st Scientific Sessions
    Via TheNewswire.com
    Exposures COVID-19
    Sernova's Principal Investigator Presents Positive New Data from Ongoing Type 1 Diabetes (T1D) Clinical Trial at ATC 2021 Virtual Connect Conference
    Via TheNewswire.com
    Exposures COVID-19
    Sernova Announces American Transplant Congress 2021 Virtual Connect Abstract Presentation
    Via TheNewswire.com
    Exposures COVID-19
    Sernova to Present at Global Partnership Family Office -- HealthCare & Biotechnology TSX Showcase
    Via TheNewswire.com
    Sernova Announces the Nomination of Seasoned Pharma Executive Dr. Mohammad Azab to its Board of Directors
    Via TheNewswire.com
    Topics Retirement
    Exposures Pension
    Sernova KOL Event Highlights Novel Cell Therapy Approach for the Potential Treatment of Thyroid Disease
    Via TheNewswire.com
    Sernova to Host a Virtual Key Opinion Leader Event on Thyroid Disease and the Potential for its Cell Therapy as a Novel Treatment Approach
    Via TheNewswire.com
    Sernova Appoints Internationally Renowned Thyroid Disease Expert Dr. Sam Wiseman to its Scientific Advisory Board
    Via TheNewswire.com
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.